E
Vor Biopharma Inc.
VOR
$0.634
$0.0142.26%
E
Sell
3/26/2025Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 3/26/2025 due to a decline in the growth index, volatility index and total return index. EBIT declined 9.81% from -$28.51M to -$31.31M, earnings per share declined from -$0.4025 to -$0.4386, and operating cash flow declined 3.34% from -$23.29M to -$24.06M.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 3/26/2025 due to a decline in the growth index, volatility index and total return index. EBIT declined 9.81% from -$28.51M to -$31.31M, earnings per share declined from -$0.4025 to -$0.4386, and operating cash flow declined 3.34% from -$23.29M to -$24.06M.
D
Sell
3/6/2025Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 3/6/2025 due to an increase in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 3/6/2025 due to an increase in the volatility index and total return index.
E
Sell
2/13/2025Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 2/13/2025 due to a decline in the volatility index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 2/13/2025 due to a decline in the volatility index.
D
Sell
1/29/2025Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 1/29/2025 due to an increase in the growth index and volatility index. EBIT increased 1.8% from -$29.04M to -$28.51M, and earnings per share increased from -$0.4076 to -$0.4025.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 1/29/2025 due to an increase in the growth index and volatility index. EBIT increased 1.8% from -$29.04M to -$28.51M, and earnings per share increased from -$0.4076 to -$0.4025.
E
Sell
7/14/2023Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 7/14/2023 due to a decline in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 7/14/2023 due to a decline in the volatility index and total return index.
D
Sell
6/29/2023Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 6/29/2023 due to an increase in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 6/29/2023 due to an increase in the volatility index and total return index.
E
Sell
6/12/2023Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 6/12/2023 due to a decline in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 6/12/2023 due to a decline in the volatility index and total return index.
D
Sell
5/23/2023Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 5/23/2023 due to an increase in the volatility index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 5/23/2023 due to an increase in the volatility index.
E
Sell
5/18/2023Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 5/18/2023 due to a decline in the volatility index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 5/18/2023 due to a decline in the volatility index.
D
Sell
5/2/2023Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 5/2/2023 due to an increase in the volatility index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 5/2/2023 due to an increase in the volatility index.
E
Sell
4/13/2023Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 4/13/2023 due to a decline in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 4/13/2023 due to a decline in the volatility index and total return index.
D
Sell
3/27/2023Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 3/27/2023 due to an increase in the solvency index, volatility index and total return index. Debt to equity declined from 0.02 to 0.01, and the quick ratio increased from 12.26 to 17.55.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 3/27/2023 due to an increase in the solvency index, volatility index and total return index. Debt to equity declined from 0.02 to 0.01, and the quick ratio increased from 12.26 to 17.55.
E
Sell
3/15/2023Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 3/15/2023 due to a decline in the volatility index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 3/15/2023 due to a decline in the volatility index.
D
Sell
3/14/2023Downgrade
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/27/2023Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 2/27/2023 due to an increase in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 2/27/2023 due to an increase in the volatility index and total return index.
D
Sell
2/23/2023Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D on 2/8/2023 due to a decline in the volatility index and total return index.
D
Sell
1/27/2023Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 1/27/2023 due to an increase in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 1/27/2023 due to an increase in the volatility index and total return index.
D
Sell
12/6/2022Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 12/6/2022 due to an increase in the volatility index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 12/6/2022 due to an increase in the volatility index.
E
Sell
11/17/2022Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 11/17/2022 due to a decline in the volatility index, growth index and solvency index. EBIT declined 10.6% from -$21.79M to -$24.1M, earnings per share declined from -$0.5785 to -$0.6259, and the quick ratio declined from 12.32 to 12.26.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 11/17/2022 due to a decline in the volatility index, growth index and solvency index. EBIT declined 10.6% from -$21.79M to -$24.1M, earnings per share declined from -$0.5785 to -$0.6259, and the quick ratio declined from 12.32 to 12.26.
D
Sell
10/21/2022Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 10/21/2022 due to an increase in the volatility index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 10/21/2022 due to an increase in the volatility index.
E
Sell
10/6/2022Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 10/6/2022 due to a decline in the volatility index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 10/6/2022 due to a decline in the volatility index.
D
Sell
9/16/2022Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 9/16/2022 due to an increase in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 9/16/2022 due to an increase in the volatility index and total return index.
E
Sell
8/31/2022Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 8/31/2022 due to a decline in the volatility index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 8/31/2022 due to a decline in the volatility index.
D
Sell
8/15/2022Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 8/15/2022 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.6097 to -$0.5785, and EBIT increased 4.42% from -$22.8M to -$21.79M.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 8/15/2022 due to an increase in the growth index, volatility index and total return index. Earnings per share increased from -$0.6097 to -$0.5785, and EBIT increased 4.42% from -$22.8M to -$21.79M.
E
Sell
5/16/2022Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 5/16/2022 due to a decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.01 to 0.04, the quick ratio declined from 20.43 to 10.01, and operating cash flow declined 30.23% from -$17.59M to -$22.9M.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 5/16/2022 due to a decline in the growth index, solvency index and volatility index. Debt to equity increased from 0.01 to 0.04, the quick ratio declined from 20.43 to 10.01, and operating cash flow declined 30.23% from -$17.59M to -$22.9M.
D
Sell
5/5/2022Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
Vor Biopharma Inc. (VOR) was upgraded to D- from E+ on 5/5/2022 due to an increase in the total return index.
E
Sell
4/20/2022Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index, total return index and valuation index.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index, total return index and valuation index.
D
Sell
11/15/2021Downgrade
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 11/15/2021 due to a decline in the growth index. Operating cash flow declined 4.7% from -$16.57M to -$17.34M, EBIT declined 1.21% from -$18.38M to -$18.6M, and earnings per share declined from -$0.4986 to -$0.5024.
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 11/15/2021 due to a decline in the growth index. Operating cash flow declined 4.7% from -$16.57M to -$17.34M, EBIT declined 1.21% from -$18.38M to -$18.6M, and earnings per share declined from -$0.4986 to -$0.5024.
D
Sell
11/9/2021Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D from E+ on 11/09/2021.
Vor Biopharma Inc. (VOR) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Vor Biopharma Inc. (VOR) was downgraded to E+ from D on 11/08/2021.
Vor Biopharma Inc. (VOR) was downgraded to E+ from D on 11/08/2021.
D
Sell
11/5/2021Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 11/5/2021 due to an increase in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 11/5/2021 due to an increase in the volatility index and total return index.
D
Sell
10/21/2021Downgrade
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 10/21/2021 due to a decline in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 10/21/2021 due to a decline in the volatility index and total return index.
D
Sell
10/4/2021Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 10/4/2021 due to an increase in the volatility index.
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 10/4/2021 due to an increase in the volatility index.
D
Sell
9/15/2021Downgrade
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 9/15/2021 due to a decline in the volatility index and total return index.
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 9/15/2021 due to a decline in the volatility index and total return index.
D
Sell
8/11/2021Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 8/11/2021 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.6715 to -$0.5, and operating cash flow increased 6.14% from -$17.65M to -$16.57M.
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 8/11/2021 due to a large increase in the growth index and volatility index. Earnings per share increased from -$0.6715 to -$0.5, and operating cash flow increased 6.14% from -$17.65M to -$16.57M.
D
Sell
7/29/2021Downgrade
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 7/29/2021 due to a substantial decline in the total return index and volatility index.
Vor Biopharma Inc. (VOR) was downgraded to D- from D on 7/29/2021 due to a substantial decline in the total return index and volatility index.
D
Sell
5/4/2021Upgraded
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 5/4/2021 due to a major increase in the total return index.
Vor Biopharma Inc. (VOR) was upgraded to D from D- on 5/4/2021 due to a major increase in the total return index.
D
Sell
5/3/2021None
Vor Biopharma Inc. (VOR) was downgraded to D- from U on 05/03/2021.
Vor Biopharma Inc. (VOR) was downgraded to D- from U on 05/03/2021.
NASDAQ
04/02/2025 4:00PM Eastern
Quotes delayed
